Subjects had to be on a maximally tolerated dose of ACE/ARB for 3 months ; stable other antihypertensive doses for 2 months ; stable diuretic dose for 2 weeks , and BP 160/90 mm Hg ; or enter a Pharmaco-Stabilization Phase ( PSP ) .